Beliefs About Medicine and Glycemic Control Among Type 2 Diabetes Patients: A Cross-Sectional Study in West Bank, Palestine.

Autor: Khdour MR; Al-Quds University, Jerusalem, Palestine., Awadallah HB; Al-Quds University, Jerusalem, Palestine., Alnadi MA; Ramallah & Al-bireh Health Directorate, West Bank, Palestine., Al-Hamed DH; Ramallah & Al-bireh Health Directorate, West Bank, Palestine.
Jazyk: angličtina
Zdroj: Journal of primary care & community health [J Prim Care Community Health] 2020 Jan-Dec; Vol. 11, pp. 2150132720971919.
DOI: 10.1177/2150132720971919
Abstrakt: Introduction: To examine the mean differences between patient beliefs about medicine with reference to adherence and glycemic control.
Methods: This study utilized a cross-sectional questionnaire-based approach. Adherence to medication was measured with the Morisky Green Levine Medication Adherence Scale (MGLS); glycemic control as the last HbA1c test value; and beliefs about medicine with the Beliefs about Medicines Questionnaire (BMQ).
Results: According to MGLS scale, 220 (57.9%) of the diabetic patients were classified as high adherent to their medications and 160 (42.1%) were classified as low adherent. Patients had strong believes in their medication, the mean necessity score was significantly outweighed the mean concerns score (17.7 vs 14.4; P  < .001). Low adherent patients had significantly more concerns about long term effect of medications (14.4 vs 13.8; P  < .008). No significant mean differences were found between glycemic controlled and uncontrolled group regarding necessity or concern domains.
Conclusion: Assessing beliefs about medicine is crucial for recognizing patients at risk of low adherence, which offers a way to help patients with diabetes to achieve a better glycemic control.
Databáze: MEDLINE